755 Research Parkway, Suite 150, Oklahoma City, OK 73104
Tel: 405-271-7848
Actionable Changes in Health
Onsite Tobacco Cessation Treatment for Patients with Peripheral Artery Disease (PAD): A Feasibility Study
Overview
Kendzor, D. E. (Principal Investigator), Hawkins, B. (Co-Principal Investigator), Bui, T. (Co-Investigator), Frank-Pearce, S. (Co-Investigator)
Tobacco cessation treatment is needed for individuals with peripheral artery disease (PAD) to improve symptoms, lower cardiovascular risk, and prevent amputation. While such treatment is effective, many PAD patients do not receive cessation therapy. This study is integrating tobacco cessation services into a dedicated PAD clinic (OU CVI Limb Preservation Clinic) to improve tobacco cessation rates and improve PAD-related health outcomes in this at risk population.
Specific Aims
-
To evaluate the feasibility of establishing an on-site visit with a tobacco treatment specialist for patients with PAD treated at the OU Cardiovascular Institute Limb Preservation Clinic (LPC).
-
To characterize the impact of tobacco cessation on subjective and objective measures of PAD and improve quality of life.
If you are a current patient at this clinic and are a tobacco user, please let your nurse know you are interested in participating.
Sponsored by Tobacco Settlement Endowment Trust/Health Promotion Research Center, The University of Oklahoma (Institutional)
2022-2023